
Marian Zuriaga
@mariaazuriaga
Postdoc at @CNIC_CARDIO. Clonal hematopoiesis, atherosclerosis, metabolism and aging.
ID: 1304423886893842437
11-09-2020 14:17:59
134 Tweet
135 Followers
298 Following

🧐New insights into the dynamics of age-related #Clonalhematopoiesis 👥Dr. José Javier Fuster and Marian Zuriaga 👍They commented on two recent articles published in nature, which provided fundamental new knowledge on the dynamics of CH. 🔗Read & Download🆓: doi.org/10.20517/jca.2…



Estrenamos los seminarios invitados de IMDEA Alimentación este miércoles 11 de enero con José Javier Fuster de @cnic. ¡No os lo perdáis! Si estás en el campus de Cantoblanco os esperamos a las 12 en el salón de actos IMDEA Alimentación



Happy to share our new collaborative article on clonal hematopoiesis, now online Nature Cardiovascular Research, this time on somatic p53 mutations and atherosclerosis rdcu.be/c3xKB A great collaboration with Derek Klarin Pradeep Natarajan Alex Bick and others! Summary of the work 👇🏼


We are #recruiting! Please see below and join us in our fight against #ovariancancer CNIO Stop Cancer #research


Dr.José Javier Fuster and Marian Zuriaga commented on two articles published in nature, which provide key new insights to understanding the factors and mechanisms that modulate the dynamics of expansion of mutant hematopoietic clones. doi.org/10.20517/jca.2…





A fantastic opportunity to be working on clonal hematopoiesis in the great team of José Javier Fuster CNIC and from very different angles! Please repost and spread the word! #CardioTwitter #CHIP #bioinformatics Center for Molecular and Vascular Biology Soc Esp Cardiología Department of Cardiovascular Sciences - KU Leuven European Society of Cardiology Nature Cardiovascular Research


Clonal hematopoiesis linked to 22% higher risk of developing T2DM (48% higher risk in those with mutations in TET2). Congrats to Deirdre Tobias, ScD and all co-authors! Consistent with Marian Zuriaga's murine work on TET2 and insulin resistance 😄doi.org/10.1016/j.celr…!

🔬Un equipo del CNIC liderado por José Javier Fuster y #ValentinFuster descubre un nuevo factor de riesgo cardiovascular, la hematopoyesis clonal, e identifica un fármaco para reducir sus efectos. Los trabajos, publicados #OpenAccess🔓 en Nature Medicine y #EHJ EHJ Editor-in-Chief


Exploring the chicken-or-egg dilemma between clonal hematopoiesis and atherosclerosis. Our latest study, published today in Nature Medicine (nature.com/articles/s4159…), addresses this critical question. Check out the thread below ⬇️

Now online simultaneously with #ESCCongress! Colchicine as a promising candidate to prevent atherosclerosis in TET2-mutant clonal hematopoiesis. A great collaboration with Pradeep Natarajan led by Marian Zuriaga and Zhi Yu. bit.ly/3T6JYFW


Truly a team effort led by Miriam Díez and Beatriz L. Ramos-Neble with Unidad de Genómica CNIC CNIC BIoIT Fatima Sanchez-Cabo Borja Ibanez Enrique Lara-Pezzi Ana García Álvarez Guiomar Mendieta Badimon Benedetta Izzi and many others CNIC

1/ 📢Descubierto un nuevo factor de riesgo cardiovascular y un fármaco que puede mitigar sus efectos. Los estudios, en los que están implicados los investigadores #CaixaResearch José Javier Fuster y Valentí Fuster CNIC, se han publicado en Nature Medicine y EHJ Editor-in-Chief.


José Javier Fuster CNIC Nature Medicine EHJ Editor-in-Chief Fundación ”la Caixa” 4/ 💉Además, los investigadores han hallado que la colchicina, un fármaco ya aprobado por las Agencias del Medicamento Europea y Americana, puede reducir el riesgo cardiovascular en personas con mutaciones en el gen TET2, asociado con la hematopoyesis clonal. 🔃
